Large scale generation and characterization of anti-human CD34 monoclonal antibody in ascetic fluid of balb/c mice
View/ Open
Date
2013Author
Maleki, LA
Majidi, J
Baradaran, B
Abdolalizadeh, J
Kazemi, T
Maleki, AA
Sepehr, KS
Metadata
Show full item recordAbstract
Purpose: Monoclonal antibodies or specific antibodies are now an essential tool of biomedical research and are of great commercial and medical value. The purpose of this study was to produce large scale of monoclonal antibody against CD34 in order to diagnostic application in leukemia and purification of human hematopoietic stem/progenitor cells. Methods: For large scale production of monoclonal antibody, hybridoma cells that produce monoclonal antibody against human CD34 were injected into the peritoneum of the Balb/c mice which have previously been primed with 0.5 ml Pristane. 5 ml ascitic fluid was harvested from each mouse in two times. Evaluation of mAb titration was assessed by ELISA method. The ascitic fluid was examined for class and subclasses by ELISA mouse mAb isotyping Kit. mAb was purified from ascitic fluid by affinity chromatography on Protein A-Sepharose. Purity of monoclonal antibody was monitored by SDS -PAGE and the purified monoclonal antibody was conjugated with FITC. Results: Monoclonal antibodies with high specificity and sensitivity against human CD34 by hybridoma technology were prepared. The subclass of antibody was IgG1 and its light chain was kappa. Conclusion: The conjugated monoclonal antibody could be a useful tool for isolation, purification and characterization of human hematopoietic stem cells. é 2013 by Tabriz University of Medical Sciences.
Collections
Related items
Showing items related by title, author, creator and subject.
-
Target therapy of cancer: Implementation of monoclonal antibodies and nanobodies
Majidi, J; Barar, J; Baradaran, B; Abdolalizadeh, J; Omidi, Y (2009)In the past decades, the mainstay of systemic therapy for solid and haematological malignancies was chemotherapy; nevertheless this modality has the drawbacks such as drug resistance and eliciting sever cytotoxicity in the ... -
Antibody humanization methods for development of therapeutic applications
Ahmadzadeh, V; Farajnia, S; Feizi, MAH; Nejad, RAK (2014)Recombinant antibody technologies are rapidly becoming available and showing considerable clinical success. However, the immunogenicity of murine-derived monoclonal antibodies is restrictive in cancer immunotherapy. Humanized ... -
A novel monoclonal antibody against a synthetic peptide from ?-actin can react with its corresponding protein
Amini, N; Bayat, A-A; Zarei, O; Hadavi, R; Mahmoudian, J; Mahmoudi, AR; Darzi, M; Rabbani, H; Jeddi-Tehrani, M (2015)Actin is one of the most widely studied structural and multifunctional housekeeping proteins in eukaryotic cells with important roles in many cell functions. Antibodies against ?-actin and other housekeeping gene-encoded ...